Skip to content
value.today

Nfocus Neuromedical, Inc.

Formerly NFOCUS INC, CardioVasc, Inc

Total raised
$15 M
2 rounds on record
Latest round
$8 M
Jul 2010
First round on record
Jun 2009
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Nfocus Neuromedical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2010$8 MNo. 2$2 to $10 million

Nfocus Neuromedical, Inc.: Raise no. 2, Jul 2010

Investors in this round

11 investors had bought by the notice of Apr 12, 2011: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $13 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Eric J Milledge · Executive Officer, Director
  • Jill Papp · Executive Officer
  • Martin Dieck · Executive Officer, Director
  • Mir A Imran · Director
  • Roger J Quy · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jill Papp, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Apr 12, 2011. Read the notice at the SEC.

equitySEC
Jun 2009$8 MNo. 1$2 to $10 million

Nfocus Neuromedical, Inc.: Raise no. 1, Jun 2009

Investors in this round

8 investors had bought by the notice of Jul 1, 2009: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $16 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jill Papp · Executive Officer
  • Martin Dieck · Executive Officer, Director
  • Eric Milledge · Director
  • Mir A. Imran · Director
  • Omar Amirana, M.D. · Director
  • Roger J. Quy · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by J. Casey McGlynn, Secretary. Source: SEC Form D, newest notice filed Jul 1, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Nfocus Neuromedical, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2011).

    SEC Form D · Apr 2011

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Apr 2011

That is all the official record says: Nfocus Neuromedical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Nfocus Neuromedical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 11 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Nfocus Neuromedical, Inc.
NameRoleNamed in
Eric J MilledgeExecutive officerApr 2011
Jill PappExecutive officerApr 2011
Martin DieckExecutive officerApr 2011
Eric J MilledgeDirectorApr 2011
Martin DieckDirectorApr 2011
Mir A ImranDirectorApr 2011
Roger J QuyDirectorApr 2011
Omar A AmiranaDirectorJul 2010
Eric MilledgeDirectorJul 2009
Mir A. ImranDirectorJul 2009
Omar Amirana, M.D.DirectorJul 2009
Roger J. QuyDirectorJul 2009